|
IDT Biologika is a German biopharmaceutical company with headquarters in Dessau-Rosslau. It develops and produces biotechnology-based vaccines and pharmaceuticals. The company is a member of the Klocke Group. == Company profile == In 2014 IDT Biologika employed around 1250 people and registered sales of €172 million. The company invests around 8% of its revenue in research and development of proprietary products each year. Company sites in Germany include the BioPharmaPark in Dessau-Rosslau and the Riems district of Greifswald. The IDT sales offices in the US, Denmark, the Netherlands, France and Spain are focused on the animal health business segment. IDT Biologika is active in the animal health, vaccines, pharmaceuticals and quality control business areas. *The Animal Health business division develops and produces animal vaccines from our own research for prophylaxis and treatment of animal diseases. Fifty veterinary medicine products for working, livestock and companion animals are used in veterinary practices. *The Vaccines division develops technologies for viral and bacterial vaccines for prophylactic and therapeutic applications, such as against malaria and HIV as well as tumor diseases. *The Pharmaceuticals division develops and produces liquid dosage forms (parenterals) in syringes, vials, ampules and bottles. This business line has also specialized in lyophilization. *Quality Control comprises analytical methods for testing vaccines and pharmaceuticals based on our own research, development and manufacturing. The company is subject to inspection by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「IDT Biologika」の詳細全文を読む スポンサード リンク
|